Found 7 matching trials
Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL
PHASE1CLL dosing escalating study; daily dosing schedule; PK/PD safety...
Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors
PHASE1The purpose of the study is to see if daily and twice daily administration ...
CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study
PHASE1The goal of this clinical research study is to study the drug CNF2024 as a ...
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding
PHASE2The purpose of this study is to assess the efficacy, safety and tolerabilit...
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors
PHASE1This study is designed to assess the effect of food and antacid use on the ...
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
PHASE1This is an open-label, multicenter, dose-escalation, safety, pharmacokineti...
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
PHASE2This study will examine the effect of BIIB021 on GIST growth and metabolism...